Sign in to continue:

Monday, July 27th, 2026

Life360, Inc. 8-K SEC Filing – Corporate Information, Address, and Regulatory Details (May 2026)

Life360, Inc. Reports Results of 2026 Annual Meeting of Stockholders

Life360, Inc. (Nasdaq: LIF) has released the official results of its 2026 Annual Meeting of Stockholders, held on May 28, 2026. The meeting was a key event for the company and its investors, with several important matters put to a shareholder vote.

Key Highlights from the Annual Meeting

  • Quorum Achieved: The meeting had strong shareholder participation, with 58,067,511 shares of common stock represented, accounting for approximately 71.96% of the 80,689,657 outstanding shares as of the April 9, 2026 record date. This ensured that a quorum was present for conducting official business.
  • Three Proposals Presented: Shareholders voted on three critical proposals:

    • Election of four Class I directors
    • Advisory vote on executive compensation
    • Ratification of the independent registered public accounting firm

Detailed Voting Results

1. Election of Directors

Shareholders elected four Class I directors to serve until the 2029 Annual Meeting. The results for each nominee were as follows:

Nominee Votes For Votes Withheld Broker Non-Votes
Chris Hulls 53,945,853 152,637 3,969,021
Alex Haro 53,468,431 3,969,021
Randi Zuckerberg 53,937,521 160,969 3,969,021

Significance: The election of directors with overwhelming support indicates strong shareholder confidence in the current leadership and strategic direction of the company. Any changes or challenges to director appointments can be price sensitive, but in this instance, the broad support is a reassuring signal for investors.

2. Advisory Vote on Executive Compensation (“Say on Pay”)

Votes For Votes Against Abstentions Broker Non-Votes
11,245,014 90,214 3,969,021

Significance: The approval—on a non-binding advisory basis—of the compensation for Life360’s named executive officers reflects investor satisfaction with how management is being incentivized. While this is advisory, a negative vote could be interpreted as a lack of confidence in management and could be price sensitive. The strong approval in this case is a positive signal.

3. Ratification of Deloitte & Touche LLP as Independent Auditor

Votes For Votes Against Abstentions Broker Non-Votes
57,817,068 177,466 72,977

Significance: The ratification of Deloitte & Touche LLP as the company’s independent registered public accounting firm for 2026 was overwhelmingly approved. A change or negative vote on auditors can often be a red flag for investors, but there is no such concern here, supporting confidence in the company’s financial controls and transparency.

Additional Shareholder Information

  • No Amendments or Emerging Growth Status: The filing confirms that this is not an amendment and that Life360 is not considered an “emerging growth company” under SEC definitions, suggesting it is subject to full public company reporting requirements.
  • No Price-Sensitive Surprises: There were no announcements of mergers, acquisitions, executive departures, or other material events that would be expected to have a direct, immediate impact on share value.

Conclusion: What Investors Should Know

  • The 2026 Annual Meeting of Life360, Inc. proceeded smoothly with all proposals passing by a wide margin, including re-election of directors, approval of executive compensation, and ratification of auditors.
  • The strong support for management and auditors is a positive signal of stability and shareholder confidence in the company’s leadership and financial reporting.
  • There are no new developments or disclosures that would be considered immediately price sensitive beyond routine governance matters.

Investor Takeaway: The uneventful nature of the annual meeting and broad shareholder support for all proposals suggest continued stability and confidence in the company’s direction. Investors should monitor future filings for any material developments.


Disclaimer: This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any securities. Investors should consult their own advisors before making investment decisions. The information presented is based on official company filings as of the date of publication and may be subject to change.

View Life360, Inc. Historical chart here



Enzon Pharmaceuticals 2024 Proxy Statement: Executive Compensation, Director Ownership, and Auditor Fees Overview

Viskase Holdings, Inc. (formerly Enzon Pharmaceuticals, Inc....

MV Oil Trust Announces Final Distribution and Dissolution Following Termination of Net Profits Interest in 2026

MV Oil Trust Announces Final Trust Distribution and Dissolut...

Liberty Global Ltd. 10-Q Q2 2026: Financial Statements, Key Investments, and Nasdaq Filings Overview

Liberty Global Ltd. Q2 2026 Financial Report: Key Highlights...